AR044371A1 - Derivados de 6,7 dimetoxi isoquinolinas, inhibidores de gfta, compuestos, procedimiento, composicion farmaceutica y usos - Google Patents
Derivados de 6,7 dimetoxi isoquinolinas, inhibidores de gfta, compuestos, procedimiento, composicion farmaceutica y usosInfo
- Publication number
- AR044371A1 AR044371A1 ARP040101698A ARP040101698A AR044371A1 AR 044371 A1 AR044371 A1 AR 044371A1 AR P040101698 A ARP040101698 A AR P040101698A AR P040101698 A ARP040101698 A AR P040101698A AR 044371 A1 AR044371 A1 AR 044371A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- substituted
- heterocyclic ring
- heteroatoms
- alkoxide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Los compuestos tienen utilidad para el tratamiento de la diabetes tipo II. Reivindicación 1: Compuestos de fórmula (1), donde: R1 es -alquilo inferior, -CH2-arilo, -cicloalquilo, -(CH2)3 -OC(=O)CH3, -alcohol inferior, -alquilo inferior-R10, - CH2COOH, o -CH2CH2OCH2CH3; R2 es -alquilo inferior, -CH2-arilo, -alcohol inferior, -CH2C(=O)NH2, o -alquilo inferior-R10, donde al menos uno de R1 o R2 es -CH3; R3 es -COOH, -alquilo inferior-COOH, -alcohol inferior, -CH2OCH3, -CH2NH2, -CH2NHSO2R11, -C(=O)R12, -CNHCH2CH2-R12, -C(=NH)-R12, -(CH2)nNHC(=O)R13, -(CH2)mC(=O)N(R15)(R16), -C(=NH)-R17, o -(CH2)n-R18; R4 es -H, -alcóxido inferior, -O-C(R7R8)C(=O)R19, -halógeno, -SCH3, -C=CHC(=O)-R10, -CH2CH2C(=O)-R10, -O-alcohol inferior, - OCH2CH(OH)CH2N=N+=N-, -OCH2CH2OCH2CH2Cl, -NHC(=O)CH2-R10, -NHC(=O)CH2-alquilo inferior, -O(CH2)n-cicloalquilo, -O-alqueno inferior, o un anillo heterocíclico insaturado de 5 miembros que contiene un heteroátomo que es S o O; R5 y R6 son cada uno independientemente -H, -halógeno o -alcóxido inferior; R7 y R8 son cada uno independientemente -H o -CH3; R10 es un heterociclilo saturado de 5 ó 6 miembros que contiene 1 ó 2 heteroátomos, donde cada heteroátomo se selecciona entre N y O y el grupo se une al resto de la molécula a un N del anillo; R11 es -CF3, -alquilo inferior, -CH2Cl, -CH2CF3, o -R12; R12 es un anillo heterocíclico de 5 ó 6 miembros saturado sustituido o no sustituido que contiene un heteroátomo que se selecciona entre N, O y S donde el anillo sustituido es el anillo heterocíclico sustituido con -OH o -fenilo; R13 es -alquilo inferior, -alcóxido inferior, o -(CH2)nR14; R14 es un anillo heterocíclico de 5 ó 6 miembros saturado o insaturado que contiene uno o dos heteroátomos que son seleccionados entre N y O; R15 es -H o -CH3; R16 es -H, -alquilo inferior, -CºN, -OH, -alcóxido inferior, o -CH2COOCH2CH3; R17 es -alcóxido inferior -NH2 o -N-alquilo inferior; R18 es un anillo heterocíclico saturado o insaturado de 5 miembros sustituido o no sustituido que contiene de 1 a 4 heteroátomos donde los heteroátomos se seleccionan entre N, O y S, donde el anillo sustituido es el anillo heterocíclico que está sustituido en uno o dos carbonos del anillo con =O, o sustituido en un N del anillo con -alcohol inferior o -alquilo inferior; R19 es -OH, -NHCH(CH3)2, -N(CH3)CH2-arilo, -N(CH3)-alquilo inferior, o la fórmula (2), o un heterociclilo de 5 ó 6 miembros saturado sustituido o no sustituido que contiene 1 ó 2 heteroátomos donde cada heteroátomo es independientemente seleccionado entre N, O y S, donde dicho heterociclilo sustituido es el heterociclilo sustituido con alquilo inferior; m es 0, 1 ó 2; n es 0 ó 1; y sus sales y ésteres farmacéuticamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47169003P | 2003-05-19 | 2003-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR044371A1 true AR044371A1 (es) | 2005-09-07 |
Family
ID=33452454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040101698A AR044371A1 (es) | 2003-05-19 | 2004-05-17 | Derivados de 6,7 dimetoxi isoquinolinas, inhibidores de gfta, compuestos, procedimiento, composicion farmaceutica y usos |
Country Status (20)
Country | Link |
---|---|
US (1) | US7067529B2 (es) |
EP (1) | EP1631551A2 (es) |
JP (1) | JP2006528218A (es) |
KR (1) | KR100785571B1 (es) |
CN (1) | CN100540537C (es) |
AR (1) | AR044371A1 (es) |
AU (1) | AU2004238521B2 (es) |
BR (1) | BRPI0410760A (es) |
CA (1) | CA2524958A1 (es) |
CL (1) | CL2004001069A1 (es) |
CO (1) | CO5630035A2 (es) |
HK (1) | HK1091838A1 (es) |
MX (1) | MXPA05012415A (es) |
MY (1) | MY142768A (es) |
NO (1) | NO20054852L (es) |
NZ (1) | NZ543065A (es) |
RU (1) | RU2320648C2 (es) |
TW (1) | TW200426144A (es) |
WO (1) | WO2004101528A2 (es) |
ZA (1) | ZA200509290B (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090325944A1 (en) * | 2006-04-12 | 2009-12-31 | Suzanne Walker Kahne | Methods and Compositions for Modulating Glycosylation |
EP2061767B1 (de) | 2006-08-08 | 2014-12-17 | Sanofi | Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung |
DE102007005045B4 (de) | 2007-01-26 | 2008-12-18 | Sanofi-Aventis | Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2008156676A1 (en) | 2007-06-15 | 2008-12-24 | President And Fellows Of Harvard College | Methods and compositions for detecting and modulating o-glycosylation |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
EP2085397A1 (en) * | 2008-01-21 | 2009-08-05 | Esteve Quimica, S.A. | Crystalline form of abacavir |
MX2010009371A (es) * | 2008-02-29 | 2010-09-14 | Procter & Gamble | Composiciones para el cuidado del pelo y metodos para incrementar el diametro del pelo. |
TW201014822A (en) | 2008-07-09 | 2010-04-16 | Sanofi Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
RU2011130793A (ru) * | 2008-12-25 | 2013-01-27 | Тайсо Фармасьютикал, Ко., Лтд. | Изохинолиновое производное |
WO2010141074A2 (en) | 2009-06-01 | 2010-12-09 | President And Fellows Of Harvard College | O-glcnac transferase inhibitors and uses thereof |
DK2470552T3 (en) | 2009-08-26 | 2014-02-17 | Sanofi Sa | NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
SG186737A1 (en) | 2010-06-23 | 2013-02-28 | Taisho Pharmaceutical Co Ltd | Isoquinoline derivative |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120050A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2012120058A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2013006758A1 (en) | 2011-07-06 | 2013-01-10 | President And Fellows Of Harvard College | Diphosphate mimetics and uses thereof |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
US10123966B2 (en) | 2013-05-16 | 2018-11-13 | The Procter And Gamble Company | Hair thickening compositions and methods of use |
CN109456268A (zh) * | 2018-11-08 | 2019-03-12 | 中国药科大学 | C1位取代的3,4-二氢异喹啉类生物碱的制备及其医药用途 |
TW202214585A (zh) * | 2020-06-08 | 2022-04-16 | 加拿大商愛彼特生物製藥公司 | 經取代之異喹啉基甲基醯胺類、其類似物及使用其之方法 |
WO2022150962A1 (en) * | 2021-01-12 | 2022-07-21 | Westlake Pharmaceutical (Hangzhou) Co., Ltd. | Protease inhibitors, preparation, and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2199462A1 (en) | 1972-09-21 | 1974-04-12 | Bruneau & Cie Lab | Papaveraldime oxime ethers and esters - analgesics and antiinflammatories prepd by treatment of papaveraldime oxime with an alkyl or acyl halide |
US4042697A (en) | 1972-10-19 | 1977-08-16 | Allen & Hanburys Limited | Isoquinolium compounds for treating diabetes |
GB1407685A (en) * | 1972-10-19 | 1975-09-24 | Allen & Hanburys Ltd | Isoquinolinium compounds |
JPS63310813A (ja) | 1987-06-12 | 1988-12-19 | Keikichi Sugiyama | 毛髪用組成物 |
US6400710B1 (en) * | 1999-07-09 | 2002-06-04 | Enron Warspeed Services, Inc. | Network with hot button for providing switched broadband multipoint/multimedia intercommunication |
ES2172376B1 (es) | 2000-01-28 | 2003-11-16 | Servier Lab | Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
-
2004
- 2004-04-19 US US10/827,514 patent/US7067529B2/en not_active Expired - Fee Related
- 2004-05-11 KR KR1020057021998A patent/KR100785571B1/ko not_active IP Right Cessation
- 2004-05-11 EP EP04732111A patent/EP1631551A2/en not_active Withdrawn
- 2004-05-11 JP JP2006529779A patent/JP2006528218A/ja active Pending
- 2004-05-11 MX MXPA05012415A patent/MXPA05012415A/es active IP Right Grant
- 2004-05-11 WO PCT/EP2004/005025 patent/WO2004101528A2/en active IP Right Grant
- 2004-05-11 AU AU2004238521A patent/AU2004238521B2/en not_active Ceased
- 2004-05-11 CA CA002524958A patent/CA2524958A1/en not_active Abandoned
- 2004-05-11 RU RU2005139524/04A patent/RU2320648C2/ru not_active IP Right Cessation
- 2004-05-11 CN CNB2004800136909A patent/CN100540537C/zh not_active Expired - Fee Related
- 2004-05-11 NZ NZ543065A patent/NZ543065A/en unknown
- 2004-05-11 BR BRPI0410760-8A patent/BRPI0410760A/pt not_active IP Right Cessation
- 2004-05-14 TW TW093113583A patent/TW200426144A/zh unknown
- 2004-05-17 MY MYPI20041856A patent/MY142768A/en unknown
- 2004-05-17 AR ARP040101698A patent/AR044371A1/es unknown
- 2004-05-17 CL CL200401069A patent/CL2004001069A1/es unknown
-
2005
- 2005-10-20 NO NO20054852A patent/NO20054852L/no unknown
- 2005-11-16 CO CO05116287A patent/CO5630035A2/es not_active Application Discontinuation
- 2005-11-16 ZA ZA200509290A patent/ZA200509290B/en unknown
-
2006
- 2006-12-12 HK HK06113605.4A patent/HK1091838A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20040259910A1 (en) | 2004-12-23 |
NO20054852D0 (no) | 2005-10-20 |
AU2004238521B2 (en) | 2007-07-26 |
MXPA05012415A (es) | 2006-02-13 |
NO20054852L (no) | 2005-12-13 |
RU2320648C2 (ru) | 2008-03-27 |
CL2004001069A1 (es) | 2005-04-01 |
CN1791581A (zh) | 2006-06-21 |
RU2005139524A (ru) | 2007-06-27 |
CA2524958A1 (en) | 2004-11-25 |
JP2006528218A (ja) | 2006-12-14 |
CN100540537C (zh) | 2009-09-16 |
CO5630035A2 (es) | 2006-04-28 |
US7067529B2 (en) | 2006-06-27 |
KR20060015267A (ko) | 2006-02-16 |
BRPI0410760A (pt) | 2006-06-27 |
HK1091838A1 (en) | 2007-01-26 |
AU2004238521A1 (en) | 2004-11-25 |
EP1631551A2 (en) | 2006-03-08 |
KR100785571B1 (ko) | 2007-12-13 |
ZA200509290B (en) | 2007-04-25 |
MY142768A (en) | 2010-12-31 |
WO2004101528A2 (en) | 2004-11-25 |
WO2004101528A3 (en) | 2005-01-06 |
TW200426144A (en) | 2004-12-01 |
NZ543065A (en) | 2009-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR044371A1 (es) | Derivados de 6,7 dimetoxi isoquinolinas, inhibidores de gfta, compuestos, procedimiento, composicion farmaceutica y usos | |
AR036114A1 (es) | Tetrahidroimidazol[1,2-a]pirazinas y tetrahidrotriazol[4,3-a]pirazinas como inhibidores de la dipeptidil peptidasa utiles para el tratamiento o la prevencion de la diabetes | |
AR113918A1 (es) | Agentes antivirales contra la hepatitis b | |
PE20020855A1 (es) | Derivados de piperazina azaindoloxoacetico sustituidos con actividad antiviral | |
AR046767A1 (es) | Inhibidores heterociclil amino de 11-beta-hidroxiesteroide deshidrogenasa tipo 1 | |
AR051403A1 (es) | Derivados de purina, purinona y deazapurina como inhibidores de la actividad de la protein quinasa; metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en la elaboracion de un medicamento para el tratamiento de enfermedades mediadas por la protein quinasa a y b. | |
PE20220931A1 (es) | Inhibidores de shp2 fosfatasa de tipo pirazolo[3,4-b]pirazina | |
PE20210128A1 (es) | Inhibidores de la ectonucleotido pirofosfatasa-fosfodiesterasa 1 (enpp-1) y usos de los mismos | |
AR035548A1 (es) | Compuestos organicos | |
AR070811A1 (es) | Derivados de 1- bencil-3- hidroximetilindazol y su utilizacion en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40 | |
AR055592A1 (es) | Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace) | |
AR029301A1 (es) | Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos | |
AR056986A1 (es) | Aza heterociclos como inhibidores de quinasas. procedimiento de obtencion y composiciones farmaceuticas | |
AR061422A2 (es) | Peptidos ciclicos selectivos, procedimiento de preparacion, composicion farmaceutica que los comprende, y uso de los mismos en la preparacion de medicamentos | |
RU2008130111A (ru) | (индазол-5-ил)пиразины и (1,3-дигидроиндол-2-он)пиразины для лечения опосредованнызх rно-киназой заболеваний и состояний | |
BR0308816A (pt) | Tiazolidina-4-carbonitrilas e análogos e seus usos como inibidores da dipeptil-peptidas | |
PE20010637A1 (es) | Derivados del acido aminodicarboxilico como estimulantes de la guanilato ciclasa | |
PE73299A1 (es) | Derivados de nicotinamida | |
KR950005308A (ko) | 직장투여용 조성물 | |
ES2191484T3 (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa. | |
ATE12492T1 (de) | Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
AR046200A1 (es) | Derivados de pirazina y su uso farmaceutico. procesos de preparacion y composiciones farmaceuticas | |
AR003947A1 (es) | Utilizacion de una cantidad efectiva de como minimo un compuesto de tipo retinoide como agente activo en una composicion cosmetica o para la fabricacionde una composicion farmaceutica, y compuestos especificos de dicho tipo. | |
AR072792A1 (es) | DERIVADOS DE PIRROLOPIRIDINILPIRIMIDIN-2-IL-AMINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS | |
PE20090620A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |